Database

Startups

Main Industry
Health Care
Main Product/Service
1. iProtin® Surface Acoustic Wave (SAW) Core Technology Platform: iProtin® is a next-generation in vitro diagnostic (IVD) solution developed by tst biomedical electronics Co., Ltd. Utilizing high-frequency reflective shear-horizontal surface acoustic wave (SH-SAW) sensor chips, it can detect real-time changes in mass and viscoelasticity on the sensing surface during antigen-antibody binding. This allows for highly sensitive quantitative or semi-quantitative detection results without the need for enzyme or fluorescent labeling. Benefiting from the unique physical properties of surface acoustic wave technology, the detection process is free from interference by blood cells, allowing the direct use of a 5 μL fingertip whole blood sample to complete high-sensitivity analysis within 3 minutes. This platform technology has obtained patents in multiple countries, features high scalability and a modular design, and can be flexibly applied to the detection of various disease biomarkers, including cardiovascular diseases, inflammatory markers, and cancer-related proteins.

2. Support for Customized Development and OEM/ODM Collaboration Models: tst biomedical electronics Co., Ltd. provides one-stop manufacturing services ranging from wafer fabrication to diagnostic biochips, assisting customers in rapidly achieving commercialization. We possess patented cavity packaging technology, which can effectively protect the surface acoustic wave sensor chip and enhance signal stability and reliability; paired with 10 nL high-precision biomaterial coating technology, it can effectively reduce production costs and facilitate biochip miniaturization. tst biomedical electronics Co., Ltd. supports customized development and OEM/ODM collaboration models, and can design chips, packaging modules, and biocoating solutions according to specific requirements, assisting academic and research institutions, startups, or corporate clients in smoothly transitioning from proof of concept and trial production to mass production.

3. The iProtin® testing platform provides API integration capabilities, which can integrate personal health indices, lifestyle habits, and medication records to achieve companion diagnostics and personalized health management. Through connections with wearable devices, health cloud platforms, or electronic medical record (EMR) systems, users can adjust exercise intensity, dietary intake, or medication dosage in real time based on test results, visualizing health data and truly implementing proactive and precise health management.
(The content above was translated by AI.)
Founded Year
2018
Unified Business No.
50907726
Status
Active
Number of Employees
0
Total Paid-in Capital
145,000,000 (NT$)
Location of Company
Taiwan , Taoyuan City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself. Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
About the Company
tst biomedical electronics Co., Ltd. – An Innovator in Biomedical Electronic Testing
tst biomedical electronics Co., Ltd. is a subsidiary of Tai-Saw Technology Co., Ltd. (TST), focusing on the innovative development of the biomedical electronics field. Combining our parent company's leading Surface Acoustic Wave (SAW) core technology with the cutting-edge R&D achievements of Japan Radio Co., Ltd. (JRC), we have successfully launched the innovative product iProtin, opening a new chapter in biomedical testing.
tst biomedical electronics Co., Ltd. upholds the philosophy of "Innovative Technology, Safeguarding Health" and is committed to promoting the popularization and innovation of Point-of-Care Testing (POCT) technology. We believe that medical testing should not be limited to traditional laboratory environments, but should be integrated into every home and every corner where it is needed, making health management more real-time and convenient.
Relying on strong cross-disciplinary integration capabilities, we closely combine precision electronic technology with biomedical applications, continuously expanding into fields such as inflammation, cancer, and chronic disease monitoring, and driving the growth and progress of future smart healthcare with our innovative technology platform. In the future, we will actively expand into international markets, promote cooperation with global medical technology leaders, build an open and diverse technology platform, and facilitate the popularization and accessibility of medical testing. tst biomedical electronics Co., Ltd. will safeguard the health of every user worldwide with precise, rapid, and easy-to-use testing solutions, marching toward a new era of smart healthcare.
(The content above was translated by AI.)



more ↓

Similar Companies

回頁面最頂端